Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and Webcast on March 15, 2022
07 März 2022 - 10:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a
specialty pharmaceutical company developing medicines for
addictions and drug overdose, today announced it will report
fourth quarter 2021 financial results and pipeline updates
on Tuesday, March 15, 2022, after U.S. financial markets
close.
The Company’s management team is scheduled to host
a conference call and webcast at 4:30 p.m.
ET on Tuesday, March 15, 2022. To access the call, please
dial 1-877-407-0792 in the U.S., or 1-201-689-8263,
outside the U.S. and provide the conference ID number:
13726931. To access the live webcast, please visit
https://themediaframe.com/mediaframe/webcast.html?webcastid=FPHqejQp.
Following the live webcast, an archived version of the call will be
available on the website.
Tuesday March 15 @ 4:30 pm ET |
Domestic: |
1-877-407-0792 |
International: |
1-201-689-8263 |
Conference ID: |
13726931 |
Webcast: |
https://themediaframe.com/mediaframe/webcast.html?webcastid=FPHqejQp |
|
|
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information visit: www.opiant.com
and follow Opiant on Twitter (@Opiant_Pharma).
For Media and Investor
Inquiries:Ben Atkins, Opiant(310)
598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Opiant Pharmaceuticals Inc (NASDAQ): 0 Nachrichtenartikel
Weitere News-Artikel